Melasma is not an autoimmune disease. It is a pigmentation disorder caused by overactive melanocytes, the cells that produce skin pigment. Unlike autoimmune conditions where the immune system attacks the body’s own tissues, melasma involves melanocytes that are functioning too much rather than being destroyed. That said, melasma does have some links to immune activity and frequently co-occurs with autoimmune thyroid disease, which is likely why this question comes up so often.
What Actually Causes Melasma
Melasma develops when melanocytes in the skin become hyperactive and start producing excess pigment, then transferring it broadly across the upper layers of the skin. The primary drivers are hormones and ultraviolet light, not immune system malfunction.
Estrogen and progesterone play a central role. Melasma commonly appears during pregnancy, while taking birth control pills, or during hormone replacement therapy. Skin affected by melasma shows higher levels of estrogen and progesterone receptors compared to surrounding healthy skin. In lab studies, melanocytes exposed to estrogen ramp up pigment production, and blocking estrogen receptors stops that process. Even in men with melasma, studies have found hormonal imbalances: lower testosterone and higher luteinizing hormone levels compared to controls.
UV radiation is considered the single most critical environmental factor. Melasma is far more common in countries near the equator with intense sun exposure. Incidence rates in Singapore, Brazil, and India are 26.8%, 27.2%, and 55.1% respectively, dramatically higher than in less sunny regions. Even minimal UV exposure triggers skin cells to release compounds that directly stimulate melanocytes. Visible light, particularly short-wavelength blue light, also contributes to pigmentation and may explain why many people with melasma relapse in summer even with diligent sunscreen use.
Several other biological pathways feed into the problem. Histamine increases pigment-producing enzyme activity in melanocytes. Melanocytes in melasma skin also show defects in autophagy, the cellular recycling process that normally clears out excess pigment. When this cleanup system fails, melanocytes retain mature pigment packets and release inflammatory signals that further drive pigmentation.
Why Melasma Gets Confused With Autoimmune Conditions
The confusion is understandable because melasma skin does show signs of low-grade inflammation. Biopsies of melasma lesions reveal infiltrates of immune cells, including certain T cells, macrophages, and mast cells, along with elevated levels of inflammatory markers like IL-17 and COX-2. This subclinical inflammation appears to sustain pigment production rather than attack the melanocytes themselves. It’s an immune-driven component of the condition, but that’s different from the immune system mistakenly targeting its own tissue, which is the hallmark of autoimmune disease.
Oxidative stress also plays a role. People with melasma have higher blood levels of a marker called malondialdehyde, a byproduct of cell damage from free radicals, and those levels correlate with how severe and widespread the melasma is. Oxidative stress contributes to several autoimmune conditions too, which adds to the surface-level resemblance.
How Melasma Differs From Vitiligo
The clearest way to understand why melasma is not autoimmune is to compare it with vitiligo, a skin condition that genuinely is. In vitiligo, the immune system’s killer T cells actively destroy melanocytes, wiping them out and leaving white patches of skin with no pigment at all. The immune attack is the primary event.
Melasma is essentially the opposite problem. Melanocytes aren’t being destroyed. They’re overproducing pigment, leading to dark patches instead of light ones. The underlying pathways are completely different: vitiligo involves immune-mediated cell death, while melasma involves hormonal signaling, UV-triggered activation, and defective pigment recycling. Notably, melasma is not treated with immunosuppressant medications. In clinical settings, melasma patients are grouped alongside people with acne and hair loss as controls who don’t require immune-suppressing drugs.
The Thyroid Connection
One real and significant overlap between melasma and autoimmune disease involves the thyroid. Studies consistently find that people with melasma have much higher rates of thyroid disorders than the general population. In one study of 84 melasma patients, thyroid disorders were detected in 58.3%, a rate four times higher than the control group. Another study found thyroid disorders in 37.8% of melasma patients versus 11.1% of controls.
The connection is especially strong in women who develop melasma during pregnancy or while using oral contraceptives. Among that group, 70% had thyroid abnormalities. Melasma patients also show significantly higher levels of anti-thyroglobulin antibodies, a marker of autoimmune thyroid disease like Hashimoto’s thyroiditis. Zinc deficiency, which is common in melasma patients (45.8% versus 23.7% in controls), may be part of the link since zinc is essential for normal thyroid function.
This doesn’t make melasma itself autoimmune. Rather, it suggests that the hormonal disruptions involved in thyroid autoimmunity, particularly shifts in estrogen and thyroid hormone levels, create conditions that trigger or worsen melasma. The two conditions share a hormonal environment, not an immune mechanism.
What This Means for Managing Melasma
Because melasma is driven by hormones, UV exposure, and cellular dysfunction rather than immune attack, treatment focuses on reducing pigment production and protecting the skin from triggers. Broad-spectrum sun protection is the foundation, including sunscreen that blocks both UV and visible light. Topical treatments that slow melanin production are the standard approach, and addressing any underlying hormonal imbalances or thyroid dysfunction can help reduce flares.
If you have melasma and a personal or family history of thyroid problems, it’s worth having your thyroid function and antibody levels checked. The high co-occurrence rate means thyroid dysfunction could be contributing to your melasma without causing obvious thyroid symptoms yet. Treating the thyroid issue won’t necessarily clear the melasma on its own, but correcting the hormonal imbalance removes one of the factors keeping the melanocytes overactive.